Skip to main content
. 2024 Jun 5;30(16):3481–3498. doi: 10.1158/1078-0432.CCR-23-3552

Table 2.

Multivariate analysis of molecular alterations and OS in patients with HGSC and ENOC.

Histotype Feature Category No. patients (events, %) HR (95% CI) P P int
HGSCa,b
RB1
Retained 3,453 (71.3) 1 [Reference]
Loss 686 (61.1) 0.74 (0.66–0.83) 6.8 × 10−7
RB1 and BRCA status
RB1 retained & gBRCAwt 714 (76.3) 1 [Reference] 0.24
RB1 loss & gBRCAwt 135 (60.7) 0.74 (0.57–0.96) 0.023
RB1 retained & gBRCAvar 159 (67.9) 0.69 (0.55–0.86) 0.001
RB1 loss & gBRCAvar 70 (42.9) 0.38 (0.25–0.58) 5.2 × 10−6
ENOCa
RB1
Retained 649 (22.7) 1 [Reference]
Loss 28 (39.3) 2.17 (1.17–4.03) 0.014
RB1 and p53
RB1 retained & p53 normal 492 (17.5) 1 [Reference] 0.698
RB1 retained & p53 abnormal 58 (36.2) 2.26 (1.38–3.71) 0.001
RB1 loss & p53 normal 11 (27.3) 1.77 (0.56–5.65) 0.332
RB1 loss & p53 abnormal 12 (58.3) 5.34 (2.43–11.8) <0.001

Abbreviation: Pint, P for interaction.

a

Adjusted for stage and age at diagnosis.

b

Stratified by study.